Elevance Health Inc (ELV)
Days of sales outstanding (DSO)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,120.57 | 1,100.87 | 326.88 | — | |
DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.33 | 0.33 | 1.12 | — |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
To analyze Elevance Health Inc's Days Sales Outstanding (DSO) trend over the past eight quarters:
1. The DSO has been relatively stable, ranging from a low of 34.11 days in Q3 2022 to a high of 38.31 days in Q4 2023.
2. There was a slight increase in DSO from Q2 2022 to Q4 2023, indicating a potential slowdown in the collection of accounts receivable.
3. However, the DSO in Q3 2022 was the lowest in the given period, suggesting an efficient collection process during that quarter.
4. Overall, Elevance Health Inc's DSO has fluctuated within a moderate range, with no significant upward or downward trends observed.
5. It is important for Elevance Health Inc to continue monitoring its DSO to ensure efficient management of accounts receivable and maintain healthy cash flow.
Peer comparison
Dec 31, 2023
See also:
Elevance Health Inc Average Receivable Collection Period (Quarterly Data)